Praxis Precision Medicines, Inc.
PRAX
$37.20
$0.792.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1,349.13% | -35.47% | -54.29% | -36.90% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,349.13% | -35.47% | -54.29% | -36.90% | -- |
| Cost of Revenue | 206.11% | 142.65% | 6.43% | 5.80% | -33.69% |
| Gross Profit | -173.18% | -147.61% | -8.34% | -6.98% | 35.54% |
| SG&A Expenses | 52.33% | 74.87% | 4.52% | 15.55% | -21.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 152.18% | 119.89% | 5.89% | 9.14% | -29.99% |
| Operating Income | -130.01% | -122.74% | -7.23% | -9.96% | 31.26% |
| Income Before Tax | -118.32% | -110.74% | 4.77% | -5.60% | 34.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -118.32% | -110.74% | 4.77% | -5.60% | 34.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -118.32% | -110.74% | 4.77% | -5.60% | 34.72% |
| EBIT | -130.01% | -122.74% | -7.23% | -9.96% | 31.26% |
| EBITDA | -130.76% | -123.34% | -7.25% | -9.97% | 31.36% |
| EPS Basic | 0.99% | -0.87% | 76.48% | 73.11% | 77.14% |
| Normalized Basic EPS | -1.35% | -0.87% | 76.48% | 73.02% | 76.46% |
| EPS Diluted | 0.99% | -0.87% | 76.48% | 73.11% | 77.14% |
| Normalized Diluted EPS | -1.35% | -0.87% | 76.48% | 73.02% | 76.46% |
| Average Basic Shares Outstanding | 120.51% | 108.91% | 304.88% | 292.76% | 185.56% |
| Average Diluted Shares Outstanding | 120.51% | 108.91% | 304.88% | 292.76% | 185.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |